Publication:
Application of nanobiotechnology for early diagnosis of SARS-CoV-2 infection in the COVID-19 pandemic

dc.contributor.coauthorSheervalilou, Roghayeh
dc.contributor.coauthorShirvaliloo, Milad
dc.contributor.coauthorSargazi, Saman
dc.contributor.coauthorShirvalilou, Sakine
dc.contributor.coauthorShahraki, Omolbanin
dc.contributor.coauthorPilehvar-Soltanahmadi, Younes
dc.contributor.coauthorSarhadi, Alireza
dc.contributor.coauthorGhaznavi, Habib
dc.contributor.coauthorKhoei, Samideh
dc.contributor.departmentN/A
dc.contributor.kuauthorNazarlou, Ziba
dc.contributor.kuprofilePhD Student
dc.contributor.schoolcollegeinstituteGraduate School of Sciences and Engineering
dc.date.accessioned2024-11-09T13:45:23Z
dc.date.issued2021
dc.description.abstractA most discussed topic of the new decade, COVID-19 is an infectious disease caused by the recently discovered SARS-CoV-2. With an exceedingly high transmission rate, COVID-19 has affected almost all the countries in the world. Absent any vaccine or specific treatment, the humanity is left with nothing but the legacy method of quarantine. However, quarantine can only be effective when combined with early diagnosis of suspected cases. With their high sensitivity and unmatched specificity, biosensors have become an area of interest for development of novel diagnostic methods. Compared to the more traditional diagnostics, nanobiotechnology introduces biosensors as different diagnostics with greater versatility in application. Today, a growing number of analytes are being accurately identified by these nanoscopic sensing machines. Several reports of validated application with real samples further strengthen this idea. As of recent, there has been a rise in the number of studies on portable biosensors. Despite the slow progression, certain devices with embedded biosensors have managed to be of diagnostic value in several countries. The perceptible increase in development of mobile platforms has revolutionized the healthcare delivery system in the new millennium. The present article reviews the most recent advancements in development of diagnostic nanobiosensors and their application in the clinical fields.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue7
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipZahedan University of Medical Sciences
dc.description.versionPublisher version
dc.description.volume105
dc.formatpdf
dc.identifier.doi10.1007/s00253-021-11197-y
dc.identifier.eissn1432-0614
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02780
dc.identifier.issn0175-7598
dc.identifier.linkhttps://doi.org/10.1007/s00253-021-11197-y
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85102596190
dc.identifier.urihttps://hdl.handle.net/20.500.14288/3613
dc.identifier.wos628080400003
dc.keywordsCOVID-19
dc.keywordsSARS-CoV-2
dc.keywords2019-nCoV
dc.keywordsNanobiotechnology
dc.keywordsBiosensor
dc.keywordsEarly diagnosis
dc.keywordsPandemic
dc.languageEnglish
dc.publisherSpringer
dc.relation.grantnoIR.ZAUMS.REC.1399.197
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9431
dc.sourceApplied Microbiology and Biotechnology
dc.subjectBiotechnology
dc.subjectApplied microbiology
dc.titleApplication of nanobiotechnology for early diagnosis of SARS-CoV-2 infection in the COVID-19 pandemic
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorNazarlou, Ziba

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
9431.pdf
Size:
994.4 KB
Format:
Adobe Portable Document Format